International Review of Ophthalmology

Previous Articles     Next Articles

Vitreomacular traction syndrome

CHEN Zheng-yu, WEI Wen-bin   

  1. Beijing Tongren Eye Center,Beijing Key Laboratory of Intraocular Tumor Diagnosis and Treatment, Beijing Key Laboratory of Ophthalmology and Visual Sciences, Beijing Tongren Hospital, Capital Medical University, Beijing 100730,China
  • Received:2018-05-08 Online:2018-08-22 Published:2018-08-28
  • Contact: WEI Wen-bin,Email:weiwenbintr@163.com E-mail:weiwenbintr@163.com
  • Supported by:

    Beijing Municipal Administration of Hospitals’Ascent Plan (DFL20150201) ; National Natural Science Foundation of China (81570891;81272981); Beijing Natural Science Foundation (7151003); Advanced Health Care Professionals Development Project of Beijing Municipal Health Bureau (2014-2-003); Capital Health Development Research Project (2016-1-2051)

Abstract:

In recent years, with the advancement in the examination of fundus diseases, a more in-depth understanding of the pathological changes, treatment methods, prognosis and influencing factors of vitreomacular traction syndrome has been made. In particular, in addition to conventional vitrectomy, Ocriplasmin intravitreal injection and pneumatic vitreolysis have gradually been introduced into the clinic; in accordance with the progress in treatment, factors that may affects the prognosis of vitreomacular traction syndrome, such as the existence and grading of premacular membrane, age, gender, the range of the vitreomacular traction and the diameter of the macular hole, was determined and clarified.